Trial intelligence / Profile preview

Collagenase Clostridium Histolyticum vs Surgery for Peyronie's Disease

NCT04786106Phase 4Active, not recruiting

Sponsor
Charitable Union for the Research and Education of Peyronie's Disease
Start
Dec 2020
Primary completion
Feb 2027
Modality
Therapeutic Enzymes
Countries
1
01

Overview

A Phase 4 trial of collagenase clostridium histolyticum in Peyronie's disease, sponsored by Charitable Union for the Research and Education of Peyronie's Disease. Started Dec 2020; status: active, not recruiting.

02

Drugs

collagenase clostridium histolyticum
03

Conditions

Peyronie's disease

Beyond the preview

Go deeper on NCT04786106.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04786106.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call